Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 4:01 pm Sale | 2023-12-31 | 13G | OCULIS HLDG AG NAMEN AKT OCS | Novartis Bioventures Ltd | 1,713,521 4.700% | -464,381 (-21.32%) | Filing History |
| 2023-03-13 08:01 am Purchase | 2023-03-02 | 13G | OCULIS HLDG AG NAMEN AKT OCS | Novartis Bioventures Ltd | 2,177,902 6.700% | 2,177,902 (New Position) | Filing History |
| 2022-02-11 4:32 pm Sale | 2021-12-31 | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | Novartis Bioventures Ltd | 673,360 2.290% | -967,786 (-58.97%) | Filing History |
| 2022-02-11 4:31 pm Sale | 2021-12-31 | 13G | FORMA THERAPEUTICS HLDGS INC FMTX | Novartis Bioventures Ltd | 1,757,057 3.710% | -1,234,648 (-41.27%) | Filing History |
| 2022-02-11 4:30 pm Sale | 2021-12-31 | 13G | GALERA THERAPEUTICS INC GRTX | Novartis Bioventures Ltd | 476,085 1.800% | -1,991,875 (-80.71%) | Filing History |
| 2022-02-11 4:30 pm Sale | 2021-12-31 | 13G | ANNEXON INC ANNX | Novartis Bioventures Ltd | 910,747 2.370% | -1,196,497 (-56.78%) | Filing History |